Organon & Co.

Organon & Co.

World Rank (Aug-2026)
4485
Market Cap (Aug-2026)
3.603 Billion USD
Market Cap (Mar-08-2026)
1.708 Billion USD
World Rank (Jan-05-2024)
3,693
Market Cap (Jan-05-2024)
3.740 Billion USD
World Rank (Jul-30-2023)
2,666
Market Cap (Jul-30-2023)
5.649 Billion USD
World Rank (Jan-07-2022)
2,198
Market Cap (Jan-07-2022)
8.195 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 902
Headquarters Country
USA
Nasdaq / NYSE Code
OGN
Employee Count
10,000
Employee Count as of Date
As on 2022
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
6,216 Million USD
Annual Net Income in USD
187 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
12,867 Million USD
Total Liabilities in USD
12,115 Million USD
Total Equity in USD
752 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
Company Website
Organon & Co.
Company Profile

Organon & Co is a Global Healthcare company with a mission to deliver impactful medicines and solutions. It is having more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergies and asthma. The headquarters is in USA.

Annual Results Summary


ORGANON & CO - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-20226,1741,705917
Dec-20216,3041,8111,351
Dec-20208,0962,7792,160
Dec-20197,7773,8403,218
Dec-20189,7772,7062,153
Balance Sheet Summary

Total Assets as on Dec-2022 was 10,955 Million USD.

Total Liabilities as on Dec-2022 was 11,847 Million USD.

Total Equity as on Dec-2022 was -892 Million USD.

Founded Year
2020
IPO Year
2021
Stock Exchange
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share